<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p><span ><strong><u>BLADDER CANCER</u></strong></span></p><p style="margin-left:0cm;text-align:justify;"><span >Bladder cancer is the second commonest urological cancer after prostate cancer. It is the commonest of all the cancers, which affect the urinary tract lining (urothelium). Males are more affected than females in a ratio of about 3:1. It is more common in the white race compared  to the black race in a ratio of 4:1. More than 80% of clients with bladder cancer are above 50 years. The commonest pathological types are</span></p><p style="margin-left:0cm;"><span >transitional cell carcinoma TCC (90%), Squamous cell carcinoma (8%) and adenocarcinoma and carcinoma in-situ (2%).</span></p><h3 style="margin-left:0cm;">CAUSES</h3><ul><li style="text-align:justify;">Chronic Infections of the bladder like <i>Schistosoma haematobium</i></li><li style="text-align:justify;">(Bilharzia) and chronic bacterial infections</li><li style="text-align:justify;">Smoking of cigarettes: cancer usually develops 10-20 years after smoking and 20 sticks a day/a packet carries a high risk of cancer development. Passive smoking may also carry the risk of cancer</li><li style="text-align:justify;">Occupational risks; environmental exposure to cancer-causing chemicals used in industries e.g. dye, textile, rubber, cable, printing etc.</li><li style="text-align:justify;">Genetic and familial factors</li></ul><h3 style="margin-left:0cm;">SYMPTOMS</h3><ul><li>May be asymptomatic in early disease (25%)</li><li>Haematuria (usually painless). Painful only in advanced disease and infection/UTI</li><li>Irritative symptoms: frequency, urgency, dysuria</li><li>Flank pain (hydronephrosis)</li><li>Pelvic pain from cancer invasion</li><li>Oedema of lower limbs from advanced disease</li></ul><h3 style="margin-left:0cm;">SIGNS</h3><ul><li>Pallor</li><li>Wasting</li><li>Palpable bladder mass</li></ul><p> </p><ul><li>Palpable kidney from ureteric obstruction and hydronephrosis</li><li>Lymphoedema of lower limb/limbs</li><li>Secondary UTI in 30% of cases</li></ul><h3 style="margin-left:0cm;">INVESTIGATIONS</h3><ul><li>FBC and ESR</li><li>Urine analysis and culture</li><li>Urine cytology</li><li>Urea, creatinine, electrolytes</li><li>Ultrasound scan: Abdominopelvic</li><li>CT Scan /MRI for staging (By specialist)</li><li>Special Investigations: Abdominopelvic IVU</li><li>Urethrocystoscopy and biopsies (By specialist)</li><li>Examination under anaesthesia (Bimanual palpation of bladder through DRE and Pelvic examinations).</li></ul><h3 style="margin-left:0cm;">TREATMENT</h3><p><strong>Treatment objectives</strong></p><ul><li>Surgical cure for early disease</li><li>Prevention of recurrence, progression and metastases</li><li>Management of complications</li><li>Additional treatment with cancer drugs and radiotherapy where necessary (Neoadjuvant and adjuvant therapy)</li></ul><h3 style="margin-left:0cm;">Non-pharmacological treatment</h3><ul><li>Cystectomy: Partial or radical with or without bladder replacement.</li><li>Radiotherapy</li></ul><h3 style="margin-left:0cm;">Pharmacological treatment</h3><p style="margin-left:0cm;"><span >Evidence Rating: [C]</span></p><ol><li><span >Early Stage</span></li></ol><p>BCG or Thiotepa bladder instillation for superficial tumours after </p><ul><li>Trans-Urethral Resection of Bladder Tumour (TURBT)</li></ul><ol><li><span >Advanced Disease</span></li></ol><ul><li>Chemotherapeutic agents recommended for advanced stage include Methotrexate, Vinblastine, Adriamycin and Cisplatin.</li></ul><h3 style="margin-left:0cm;"> </h3><p style="margin-left:0cm;"> </p><h3 style="margin-left:0cm;">REFERRAL CRITERIA</h3><p style="margin-left:0cm;text-align:justify;"><span >Refer all cases of bladder cancer for specialist evaluation and treatment. All cases of chronic cystitis should be referred to specialist to exclude bladder cancer.</span></p>
</body>
</html>
